Fluoxetine vs CYP2C9 Inhibitors (Moderate)

Interacting Drugs
Fluoxetine
vs
CYP2C9 Inhibitors (Moderate)
Security Level
Minor, Monitor Therapy
Mechanism
CYP2C9 Inhibitors (Moderate): May decrease the metabolism of CYP2C9 Substrates (High risk).
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Fluoxetine vs CYP2C9 Inhibitors (Moderate)